Myungmoon Phar (017180) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.005x

Based on the latest financial reports, Myungmoon Phar (017180) has a cash flow conversion efficiency ratio of 0.005x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩519.72 Million ≈ $352.20K USD) by net assets (₩104.46 Billion ≈ $70.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 017180 net asset quality index to measure how much of total assets are equity-financed.

Myungmoon Phar - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Myungmoon Phar's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 017180 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Myungmoon Phar Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Myungmoon Phar ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Comelf SA RO:CMF	-0.012x
Kyobo 8 Special Purpose Acquisition Company KQ:307280	0.063x
JPMorgan American Investment Trust LSE:JAM	0.003x
Is Girisim Sermayesi Yatirim Ortakligi AS IS:ISGSY	-0.007x
Advancecon Holdings Bhd KLSE:5281	0.155x
Korean Drug Co. Ltd KQ:014570	0.080x
FIGENE CAPITAL SA ZY 1 F:20X	N/A
Choo Bee Metal Industries Bhd KLSE:5797	0.051x

Annual Cash Flow Conversion Efficiency for Myungmoon Phar (2010–2025)

The table below shows the annual cash flow conversion efficiency of Myungmoon Phar from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Myungmoon Phar.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩104.46 Billion ≈ $70.79 Million	₩-1.70 Billion ≈ $-1.15 Million	-0.016x	-25.76%
2024-12-31	₩103.12 Billion ≈ $69.88 Million	₩-1.34 Billion ≈ $-906.54K	-0.013x	+77.78%
2023-12-31	₩88.75 Billion ≈ $60.15 Million	₩-5.18 Billion ≈ $-3.51 Million	-0.058x	-201.57%
2022-12-31	₩95.27 Billion ≈ $64.56 Million	₩5.47 Billion ≈ $3.71 Million	0.057x	+477.20%
2021-12-31	₩85.87 Billion ≈ $58.20 Million	₩855.00 Million ≈ $579.42K	0.010x	+105.42%
2020-12-31	₩90.77 Billion ≈ $61.52 Million	₩-16.67 Billion ≈ $-11.30 Million	-0.184x	-400.89%
2019-12-31	₩80.20 Billion ≈ $54.35 Million	₩-2.94 Billion ≈ $-1.99 Million	-0.037x	-129.92%
2018-12-31	₩93.06 Billion ≈ $63.07 Million	₩11.41 Billion ≈ $7.73 Million	0.123x	+55.39%
2017-12-31	₩101.72 Billion ≈ $68.93 Million	₩8.02 Billion ≈ $5.44 Million	0.079x	+33.34%
2016-12-31	₩94.68 Billion ≈ $64.16 Million	₩5.60 Billion ≈ $3.80 Million	0.059x	+172.13%
2015-12-31	₩67.12 Billion ≈ $45.49 Million	₩-5.50 Billion ≈ $-3.73 Million	-0.082x	-16457.33%
2014-12-31	₩73.15 Billion ≈ $49.57 Million	₩-36.23 Million ≈ $-24.56K	0.000x	-101.81%
2013-12-31	₩73.20 Billion ≈ $49.60 Million	₩2.00 Billion ≈ $1.36 Million	0.027x	-28.27%
2012-12-31	₩72.87 Billion ≈ $49.38 Million	₩2.78 Billion ≈ $1.88 Million	0.038x	-10.77%
2010-12-31	₩67.13 Billion ≈ $45.49 Million	₩2.87 Billion ≈ $1.95 Million	0.043x	--

About Myungmoon Phar

KO:017180 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$24.67 Million

₩36.40 Billion KRW

Market Cap Rank

#24366 Global

#1705 in Korea

Share Price

₩1072.00

Change (1 day)

+1.42%

52-Week Range

₩1057.00 - ₩1945.00

All Time High

₩10277.86